UCHL1 Knockout Cell Line (A549)

The choice depends on whether you are studying UCHL1's deubiquitinase activity, its ubiquitin ligase activity at higher concentrations, or its role in neurodegeneration. The Knockout line is the standard tool for asking whether UCHL1 is required for ubiquitin homeostasis, neuronal function, or — relevantly in A-549 — its reported roles in cancer biology and lung cancer progression. Overexpression is useful for studying UCHL1's gain-of-function activity in neurodegeneration and for distinguishing concentration-dependent enzymatic functions. For UCHL1 research, the EDITGENE Knockout line in A-549 is particularly informative for cancer biology questions because A-549 is the standard NSCLC model. Rescue with wild-type or catalytically-dead (C90S) UCHL1 is essential — UCHL1 has both deubiquitinase and ligase activities, and concentration-dependent rescue is informative for distinguishing these functions.

Primary applications: • Ubiquitin homeostasis: free ubiquitin pool measurement and ubiquitinated proteome analysis to assess UCHL1's role in maintaining cellular ubiquitin levels. • Cancer phenotype assays: A-549-relevant readouts including proliferation, apoptosis sensitivity, and invasion assays — UCHL1 has reported context-dependent oncogenic and tumor-suppressive functions in lung cancer. • Deubiquitinase versus ligase activity: comparison of UCHL1's two reported enzymatic activities through differential rescue experiments using wild-type and catalytically modified variants. • Inhibitor specificity: critical genetic control for testing UCHL1 inhibitors (e.g., LDN-57444) for on-target activity. EDITGENE recommends this model for researchers investigating UCHL1 biology, lung cancer-relevant ubiquitination, and UCHL1 inhibitor pharmacology.

Yes. UCHL1 rescue experiments have a well-defined framework given UCHL1's prominence in neurodegeneration research: • Construct design: use a codon-modified UCHL1 sequence with a small N- or C-terminal tag (FLAG, HA). UCHL1 is small (~223 amino acids); both tag positions are tolerated. • Catalytically-dead rescue: the C90S mutation abolishes deubiquitinase activity and is essential for distinguishing UCHL1's enzymatic activity from its concentration-dependent ligase activity. • Concentration-dependent rescue: UCHL1 has been reported to exhibit ligase activity at high concentrations — titrate expression levels to physiological ranges using inducible systems where possible. • Inhibitor specificity controls: rescue with wild-type versus catalytic mutants helps distinguish on-target effects of UCHL1 inhibitors (LDN-57444, others) from off-target activities. A-549 transduces efficiently with lentivirus and supports stable rescue line generation; the NSCLC background is particularly relevant for cancer-focused rescue studies.